HVC
SEEL

Healthcare Value Capital’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Healthcare Value Capital’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Hold
0
– -$99K – 34
2015
Q4 		– Hold
0
– – – 22
2015
Q3 		– Hold
0
– – – 28

Other funds holding SEEL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Healthcare Value Capital's SEEL Position: Q4 2018 in Review

Healthcare Value Capital sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2018, closing a stake of 1 share — an estimated $31K sold.

Healthcare Value Capital first reported a position in SEEL in Q2 2015 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 7 funds tracked by Wall St. Rank hold SEEL as of Q4 2018.

  • Healthcare Value Capital reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Healthcare Value Capital sold 1 Seelos Therapeutics, Inc. Common Stock share in Q4 2018, an estimated $31K.
  • Healthcare Value Capital first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
  • Healthcare Value Capital's Seelos Therapeutics, Inc. Common Stock position peaked at $1.11M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Healthcare Value Capital's 13F filing for Q4 2018, filed 13 Feb 2019.